Loading...
Serum
India Pharmaceutical Trade Intelligence
Who Supplies Serum to India from SPAIN
India's serum imports from SPAIN total $1.7B across 126 shipments from 15 foreign suppliers. GRIFOLS WORLDWIDE OPERATION LTD. leads with $1.7B in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include GRIFOLS INDIA HEALTHCARE PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for serum — a diversified sourcing base with multiple active suppliers from SPAIN.
Top foreign suppliers (SPAIN) — Ranked by import value
GRIFOLS WORLDWIDE OPERATION LTD. is the leading Serum supplier from SPAIN to India, with import value of $1.7B across 10 shipments. The top 5 suppliers — GRIFOLS WORLDWIDE OPERATION LTD., GRIFOLS WORLDWIDE OPERATION LT, GRIFOLS WORLDWIDE OPERATION LIMITED, SPINREACT, S.A.U., SPINREACT S.A — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (SPAIN)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | GRIFOLS WORLDWIDE OPERATION LTD. | $1.7B | 10 | 99.6% |
| 2 | GRIFOLS WORLDWIDE OPERATION LT | $6.0M | 1 | 0.4% |
| 3 | GRIFOLS WORLDWIDE OPERATION LIMITED | $115.7K | 1 | 0.0% |
| 4 | SPINREACT, S.A.U. | $66.2K | 50 | 0.0% |
| 5 | SPINREACT S.A | $41.4K | 14 | 0.0% |
| 6 | SPINREACT S.A.U. | $17.4K | 6 | 0.0% |
| 7 | SPINREACT SAU | $14.0K | 10 | 0.0% |
| 8 | SPINREACT,S.A.U. | $7.0K | 4 | 0.0% |
| 9 | M S FUNDACIO DE RECERCA CLINIC BAR | $3.8K | 1 | 0.0% |
| 10 | SPINREACT S.A.U | $3.8K | 6 | 0.0% |
| 11 | M/S. HOSPITAL CLINIC BARCELONA (HCB | $2.5K | 8 | 0.0% |
| 12 | SPINREACT S A | $2.2K | 2 | 0.0% |
| 13 | SPINEREACT, S.A.U. | $1.3K | 1 | 0.0% |
| 14 | ANAPATH RESEARCH S.A.U. | $509 | 6 | 0.0% |
| 15 | SPINREACT, S.A.U | $394 | 3 | 0.0% |
Showing top 15 of 15 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from SPAIN)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | GRIFOLS INDIA HEALTHCARE PRIVATE LIMITED | $1.7B | 12 | 100.0% |
| 2 | TRANSASIA BIO-MEDICALS LIMITED | $124.5K | 49 | 0.0% |
| 3 | TRANSASIA BIO MEDICALS LTD | $8.5K | 2 | 0.0% |
| 4 | TULIP DIAGNOSTICS PRIVATE LIMITED | $7.9K | 4 | 0.0% |
| 5 | TRANSASIA BIO MEDICALS LIMITED | $7.3K | 6 | 0.0% |
| 6 | IMMUNEEL THERAPEUTICS PRIVATE LIMITED | $6.4K | 9 | 0.0% |
| 7 | PEERLESS BIOTECH PRIVATE LIMITED | $5.1K | 33 | 0.0% |
| 8 | INTOX PRIVATE LIMITED | $509 | 6 | 0.0% |
| 9 | PEERLESS BIOTECH PRIVATE LTD | $263 | 2 | 0.0% |
| 10 | SATNAM AND COMPANY | $161 | 1 | 0.0% |
| 11 | All Ministries / Departments of Central Government | $18 | 1 | 0.0% |
| 12 | DR.REDDY'S LABORATORIES LTD | $5 | 1 | 0.0% |
Import Statistics
- Import Value
- $1.7B
- Shipments
- 126
- Foreign Suppliers
- 15
- Indian Buyers
- 12
- Avg. Shipment
- $13.4M
Other Serum Import Origins
Frequently Asked Questions — Serum Imports from SPAIN
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Serum suppliers from SPAIN to India?
The top Serum suppliers from SPAIN to India include GRIFOLS WORLDWIDE OPERATION LTD., GRIFOLS WORLDWIDE OPERATION LT, GRIFOLS WORLDWIDE OPERATION LIMITED. The leading supplier is GRIFOLS WORLDWIDE OPERATION LTD. with import value of $1.7B USD across 10 shipments. India imported Serum worth $1.7B USD from SPAIN in total across 126 shipments.
QHow much Serum does India import from SPAIN?
India imported Serum worth $1.7B USD from SPAIN across 126 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Serum from SPAIN?
The main Indian buyers of Serum sourced from SPAIN include GRIFOLS INDIA HEALTHCARE PRIVATE LIMITED, TRANSASIA BIO-MEDICALS LIMITED, TRANSASIA BIO MEDICALS LTD. The largest buyer is GRIFOLS INDIA HEALTHCARE PRIVATE LIMITED with $1.7B in imports across 12 shipments.
QWhat is the total value of Serum imports from SPAIN to India?
The total value of Serum imports from SPAIN to India is $1.7B USD, across 126 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: SPAIN to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Serum.
- 2.Supplier/Buyer Matching: 15 foreign suppliers from SPAIN and 12 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $1.7B aggregated from 126 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
126 Verified Shipments
15 suppliers, 12 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists